Ironwood Pharmaceuticals, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $34.3M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $76.1M |
| SG&A Expense | $19.0M |
| Operating Income | $-60.8M |
| Operating Margin | -177.2% |
| Interest Expense | $318.0K |
| Pretax Income | $-60.3M |
| Income Tax Expense | $-296.0K |
| Net Income | $-73.3M |
| Net Margin | -213.6% |
| EPS (Basic) | $-10.00 |
| EPS (Diluted) | $-10.00 |
| Shares Outstanding (Basic) | 7.1M |
| Shares Outstanding (Diluted) | 7.1M |
| Dividends Per Share | — |